title: Management and long-term results of surgery for localized gastric lymphomas.
abstract: BACKGROUND
  High- and low-grade gastric lymphomas (GL) differ in their behavior and chemosensitivity. Surgery has to be reevaluated according to the histologic grade of malignancy. We aimed to assess the place of surgery in the management of GL and its results after long-term follow-up.
  
  
  METHODS
  Among 54 patients with primary GL prospectively enrolled from 1984 to 1990, 45 with localized disease were studied. Primary resection was done whenever safe. All patients received chemotherapy adapted to the grade of malignancy and/or to the completeness of the resection.
  
  
  RESULTS
  Among 18 low- and 27 high-grade GL, 35 patients had primary resections; of those, 23 were complete. The complete response rate for all patients with low- and high-grade GL was 67% and 89%, respectively. After a median follow-up of 8 years, the disease-free survival rates for low-grade GL and high-grade GL were 94% and 89%, respectively. It was better after complete resection.
  
  
  CONCLUSIONS
  Complete resection is a major determinant of prolonged complete remission.
authors.affiliation: Centre de Chirurgie Digestive, Hôpital Saint Antoine, Paris, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Vaillant
authors.forename: A
authors.initials: A
authors.lastname: Ruskoné-Fourmestraux
authors.forename: P
authors.initials: P
authors.lastname: Aegerter
authors.forename: B
authors.initials: B
authors.lastname: Gayet
authors.forename: J C
authors.initials: JC
authors.lastname: Rambaud
authors.forename: P
authors.initials: P
authors.lastname: Valleur
authors.forename: R
authors.initials: R
authors.lastname: Parc
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy; D006801:Humans; D016014:Linear Models; D008137:Longitudinal Studies; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D011446:Prospective Studies; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome